Prognosis of non-surgically treated, clinical stage I lung cancer patients in Japan

被引:43
作者
Motohiro, A
Ueda, H
Komatsu, H
Yanai, N
Mori, T
机构
[1] Natl Minamifukuoka Chest Hosp, Dept Surg, Minami Ku, Fukuoka 815, Japan
[2] Natl Shinseirakusen Hosp, Dept Surg, Gunma 3771711, Japan
[3] Natl Seiranso Chest Hosp, Dept Surg, Tokai, Ibaragi 31911, Japan
[4] Natl Kinki Chuoh Chest Hosp, Dept Surg, Sakai, Osaka 5918555, Japan
关键词
lung cancer; prognostic value; survival; stage I; non-surgical treatment;
D O I
10.1016/S0169-5002(01)00459-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The optimal management of stage I lung cancer is surgical resection. However, some of these patients are not candidates for surgery because of several medical problems. We analyzed prognosis of non-surgically treated, clinical stage I lung cancer patients. Methods and Results: There were 21211 lung cancer patients registered from 1982 to 1991 in the data-base of the Japanese National Chest Hospital Study Group for Lung Cancer, and the number of non-surgically treated, clinical stage I lung cancer patients during the 10 years was 802. The 5- and 10-year survival rates of the 799 patients, exclusive of two carcinoid tumors and one adenid cystic carcinoma which have good prognosis, were 16.6 and 7.4%. We analyzed the 799 patients according to several prognostic factors. Sex, T factor of the tumor, histology, performance status and the method in which lung cancer was detected were prognostic factors, but age and treatment method were not associated with prognosis. Forty-nine patients survived for 5 years or more without surgical resection, but the survival rate continued to decrease even after 5 years, and the 7- and 10-year survival rates were 34.4 and 18.1% in the 49 patients. Conclusions: It is a fact that there are long-term survivors in non-surgically treated, stage I lung cancer patients. However, the rate is low, and the survival curve continues to decrease even after 5 years. Long-term survivors might suggest the presence of a lung cancer in which the tumor growth is slow. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 25 条
[1]  
ARAI T, 1994, JPN J CLIN ONCOL, V24, P199
[2]   Screening for cancer: Future potential [J].
Cuzick, J .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (05) :685-692
[3]  
FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO
[4]  
2-0
[5]   Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer [J].
Hayakawa, K ;
Mitsuhashi, N ;
Saito, Y ;
Nakayama, Y ;
Furuta, M ;
Sakurai, H ;
Kawashima, M ;
Ohno, T ;
Nasu, S ;
Niibe, H .
LUNG CANCER, 1999, 26 (03) :137-142
[6]  
Itoh S, 1998, Radiat Med, V16, P75
[7]   5-YEAR DISEASE-FREE SURVIVAL OF A LUNG-CANCER PATIENT TREATED ONLY BY PHOTODYNAMIC THERAPY [J].
KATO, H ;
KONAKA, C ;
KAWATE, N ;
SHINOHARA, H ;
KINOSHITA, K ;
NOGUCHI, M ;
OOTOMO, S ;
HAYATA, Y .
CHEST, 1986, 90 (05) :768-770
[8]   The influence of lung cancer mass screening on surgical results [J].
Koike, T ;
Terashima, M ;
Takizawa, T ;
Haga, M ;
Kurita, Y ;
Yokoyama, A ;
Misawa, H .
LUNG CANCER, 1999, 24 (02) :75-80
[9]  
KOMAKI R, 2000, LUNG CANCER S4, V29, P153
[10]   LONG-TERM SURVIVAL IN SMALL-CELL LUNG-CANCER - POSTTREATMENT CHARACTERISTICS IN PATIENTS SURVIVING 5 TO 18+ YEARS - AN ANALYSIS OF 1,714 CONSECUTIVE PATIENTS [J].
LASSEN, U ;
OSTERLIND, K ;
HANSEN, M ;
DOMBERNOWSKY, P ;
BERGMAN, B ;
HANSEN, HH .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) :1215-1220